BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1655245)

  • 1. Allelotype of human ovarian cancer.
    Sato T; Saito H; Morita R; Koi S; Lee JH; Nakamura Y
    Cancer Res; 1991 Oct; 51(19):5118-22. PubMed ID: 1655245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelotype of papillary serous peritoneal carcinomas.
    Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
    Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epithelial ovarian cancer allelotype.
    Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
    Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2.
    Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK
    Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allelic losses of tumor suppressor gene on chromosome 17 in ovarian cancer].
    Sakamoto T; Ogino M; Yamamoto T; Mori H; Okinaga S; Sonoda T; Ueda K; Obi S; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):457-63. PubMed ID: 8496636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
    Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
    Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
    Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
    Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers.
    Saito S; Saito H; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1992 Oct; 52(20):5815-7. PubMed ID: 1394208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.
    Sato S; Nakamura Y; Tsuchiya E
    Cancer Res; 1994 Nov; 54(21):5652-5. PubMed ID: 7923212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.
    Devilee P; van Vliet M; van Sloun P; Kuipers Dijkshoorn N; Hermans J; Pearson PL; Cornelisse CJ
    Oncogene; 1991 Sep; 6(9):1705-11. PubMed ID: 1681492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotype analysis of childhood acute lymphoblastic leukemia.
    Takeuchi S; Bartram CR; Wada M; Reiter A; Hatta Y; Seriu T; Lee E; Miller CW; Miyoshi I; Koeffler HP
    Cancer Res; 1995 Nov; 55(22):5377-82. PubMed ID: 7585604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel 4 cM minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas.
    Colitti CV; Rodabaugh KJ; Welch WR; Berkowitz RS; Mok SC
    Oncogene; 1998 Jan; 16(4):555-9. PubMed ID: 9484846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
    Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
    Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelotype of pancreatic adenocarcinoma using xenograft enrichment.
    Hahn SA; Seymour AB; Hoque AT; Schutte M; da Costa LT; Redston MS; Caldas C; Weinstein CL; Fischer A; Yeo CJ
    Cancer Res; 1995 Oct; 55(20):4670-5. PubMed ID: 7553647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.